2-amino-4-phenylquinazoline derivates and their use as HSP90 modulators

Details for Australian Patent Application No. 2006246744 (hide)

Owner Merck Patent GmbH

Inventors Wolf, Michael; Buchstaller, Hans-Peter; Eggenweiler, Hans-Michael

Agent Davies Collison Cave

Pub. Number AU-B-2006246744

PCT Pub. Number WO2006/122631

Priority 10 2005 022 977.8 19.05.05 DE

Filing date 24 April 2006

Wipo publication date 23 November 2006

Acceptance publication date 3 November 2011

International Classifications

C07D 239/84 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

24 January 2008 PCT application entered the National Phase

  PCT publication WO2006/122631 Priority application(s): WO2006/122631

3 November 2011 Application Accepted

  Published as AU-B-2006246744

1 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006246751-Bioresorbable fillers constituted by phospholipid liposomes and hyaluronic acid and/or the derivatives thereof

2006246743-Compounds for organic electronic devices